Inventor · disambiguated record
Philippe Soubrie
Also filed as: SOUBRIE PHILIPPE
11 granted patents·5 pending applications·299 citations·filing 1989–2008
91Inventor score
Top patents by PatentIndex Score
16 records- 0192US6344474B1Use of central cannabinoid receptor antagonists for regulating appetenceSANOFI SYNTHELABO·Filed 1998·Granted Feb 5, 2002·196 cites·13 claims
- 0288US5082858ANovel chroman derivatives active on the central nervous system, their method of preparation and pharmaceutical compositions in which they are presentSANOFI SA·Filed 1989·Granted Jan 21, 1992·34 cites·6 claims
- 0378US6573281B1Use of saredutant for the treatment of adaptation, bipolar, and dysthymic disordersSANOFI SYNTHELABO·Filed 2000·Granted Jun 3, 2003·11 cites·4 claims
- 0477US6420388B1Osanetant in the treatment of depression and depressive disordersSANOFI SYNTHELABO·Filed 2000·Granted Jul 16, 2002·12 cites·7 claims
- 0576US5151442AChroman derivative active on the central nervous system, their method of preparation and pharmaceutical compositions in which they are presentSANOFI SA·Filed 1991·Granted Sep 29, 1992·15 cites·4 claims
- 0669US5026716AMethod of treatment of anxiety and anxio-depressive disordersSANOFI SA·Filed 1989·Granted Jun 25, 1991·15 cites·7 claims
- 0759US2008227818A1Use of saredutant or its pharmaceutically acceptable salts in the treatment of mixed anxiety-depression disordersSANOFI AVENTIS·Filed 2008·Application pending·0 cites
- 0858US2005148614A1Combination of active ingredients for the treatment of senile dementia of the Alzheimer typeSANOFI AVENTIS·Filed 2005·Application pending·0 cites
- 0955US2003092737A1Combination of active ingredients for the treatment of senile dementia of the Alzheimer typeFiled 2002·Application pending·0 cites
- 1054US7390823B2Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disordersSANOFI AVENTIS·Filed 2003·Granted Jun 24, 2008·0 cites·1 claims
- 1154US5604245AUse of 4-amino-1-(2-pyridyl)piperidines for the preparation of a medicament for the treatment of conditions deriving from disorders of the serotoninergic systems mediated by 5-HT3 receptorsSANOFI ELF·Filed 1992·Granted Feb 18, 1997·10 cites·8 claims
- 1250US2005026986A1Use of central cannabinoid receptor antagonists for the preparation of drugsFiled 2004·Application pending·0 cites
- 1345US5043352AChroman derivatives for the treatment of depressive statesSANOFI SA·Filed 1989·Granted Aug 27, 1991·4 cites·4 claims
- 1443US2002128302A1Use of central cannabinoid receptor antagonists for the preparation of drugsFiled 2002·Application pending·0 cites
- 1532US5286734AArylpiperidine derivative, process for the preparation thereof and pharmaceutical compositions containing itSANOFI ELF·Filed 1993·Granted Feb 15, 1994·1 cites·5 claims
- 1626US5852044AUse of NK1 receptor antagonists for preparing cardio-regulatory drugsSANOFI SA·Filed 1997·Granted Dec 22, 1998·1 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Philippe Soubrie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →